Head and neck cancer shows major shifts in cellular energy use, blocking these pathways can unlock new cancer immunotherapies ...

Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer ...

A NEW test has been found to identify head and neck cancers caused by human papillomavirus (HPV) up to 10 years before ...

Mass General Brigham researchers have developed a groundbreaking blood test named HPV-DeepSeek that can detect HPV-associated ...

A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with ...

Researchers hope the advanced warning could enable earlier, less invasive treatments with fewer side effects and better outcomes.

Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year.

Mass General Brigham’s HPV-DeepSeek test achieves much earlier blood-based cancer detection, opening new path for HPV-associated head and neck cancer screening.

Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide and claiming hundreds of thousands of lives each year.

Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus ...

In a study published in the Journal of the National Cancer Institute, Mass General Brigham researchers show that a novel ...

Half-Year Results and Business UpdatePositive Phase I data with TG4050 in operable Head and Neck Squamous Cell Carcinoma (HNSCC) 100% ...